ValiRx plc http://www.alacrastore.com/company-snapshot/ValiRx_plc-2111677 Friday, January 09, 2009 3:00:20 AM 2111677 ValiRx plc en AlacraStore RSS Builder 1.0 30 BELGIUM - Biofield Corp (BC) of the US agreed to acquire a ##% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnostic products, from ValiRx PLC, for #.# mil euros ($#.### mil US) in cash. Concurrently, BC was granted an option to raise its stake to ##% from ##%, by acquiring a ##% stake in VS.12/17/2008 2:20:08 PM09059191952J09059191939WBiofield CorpValiBIO SABiofield CorpValiRx PLChttp://www.alacrastore.com/storecontent/Thomson_M%26A/Biofield_Corp_acquires_a_minority_stake_in_ValiBIO_SA_from_ValiRx_PLC-2035621040sdc/20356210402035621040Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqMeasuring, Medical, Photo Equipment; ClocksUnited StatesElectromedical and electrotherapeutic apparatus3845GAGeorgiaPublicBZET3845:Electromedical and electrotherapeutic apparatus3845:Electromedical and electrotherapeutic apparatusMeasuring, Medical, Photo Equipment; ClocksBelgiumLaboratory apparatus and furniture3821FFForeignSubsidiary279910002Mnfr breast cancer detect sysBiotechnology companyCashCash OnlyStock1058011001Dec 17 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000Biofield Corp, based inAlpharetta, Georgia,manufactures and developsnon-invasive, portable,cost-effective technology fordetection of breast cancercalled Biofield BreastProliferation Detection System(BDS). The company wasestablished in 1992.Biofield Corp, based in Alpharetta, Georgia, manufacturesand develops non-invasive, portable, cost-effectivetechnology for detection of breast cancer called BiofieldBreast Proliferation Detection System (BDS). The company wasestablished in 1992.Biofield Corp, based in Alpharetta, Georgia, manufactures and develops non-invasive, portable, cost-effective technology for detection of breast cancer called Biofield Breast Proliferation Detection System (BDS). The company was established in 1992.1.000002.000003.000004.000005.000006.000007.000008.00000ValiBIO SA, based inGosselies, BElgium,manufactures cancer diagnosticproducts in 3 main areas:Nucleosomics, Hypergenomicsand HPV diagnostic tests. Thecompany was established inJuly 2007.ValiBIO SA, based in Gosselies, BElgium, manufactures cancerdiagnostic products in 3 main areas: Nucleosomics,Hypergenomics and HPV diagnostic tests. The company wasestablished in July 2007.ValiBIO SA, based in Gosselies, BElgium, manufactures cancer diagnostic products in 3 main areas: Nucleosomics, Hypergenomics and HPV diagnostic tests. The company was established in July 2007.0.000000.000000.000000.00000YEURO15 Dec 08Mon, 15 Dec 2008 00:00:00 ESTDate Announced: 12/15/2008Date Effective:Acq. Part. Int.Friendly0.000000.000000.000006.000000.000000.00000Price/Share0.000000.6 EURO0.600006.000000.6 EURO0.600000.000000.000000.000000.000000.600000.6 EURO1.37200N0.537000.000000.000000.000000.000000.000000.823000.823000.000000.000000.000000.000000.000000.000000.000000.0000010.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000008.229000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.00000BELGIUM - Biofield Corp (BC)of the US agreed to acquire a10% stake in ValiBIO SA (VS),a Gosselies-based manufacturerof cancer diagnostic products,from ValiRx PLC, for 0.6 mileuros ($0.823 mil US) in cash.Concurrently, BC was grantedan option to raise its staketo 25% from 10%, by acquiringa 15% stake in VS.BELGIUM - Biofield Corp (BC) of the US agreed to acquire a 10% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnostic products, from ValiRx PLC, for 0.6 mil euros ($0.823 mil US) in cash. Concurrently, BC was granted an option to raise its stake to 25% from 10%, by acquiring a 15% stake in VS.BELGIUM - Biofield Corp (BC) of the US agreed to acquire a 10% stake in ValiBIO SA (VS), aGosselies-based manufacturer of cancer diagnostic products, from ValiRx PLC, for 0.6 mileuros ($0.823 mil US) in cash. Concurrently, BC was granted an option to raise its staketo 25% from 10%, by acquiring a 15% stake in VS.BELGIUM - Biofield Corp (BC) of the US agreed to acquire a 10% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnostic products, from ValiRx PLC, for 0.6 mil euros ($0.823 milUS) in cash. Concurrently, BC was granted an option to raise its stake to 25% from 10%, by acquiring a 15% stake in VS.BELGIUM - Biofield Corp (BC) of the US agreed to acquire a 10% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancerdiagnostic products, from ValiRx PLC, for 0.6 mil euros ($0.823 mil US) in cash. Concurrently, BC was granted an option to raise itsstake to 25% from 10%, by acquiring a 15% stake in VS.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000003821:Laboratory apparatus and furniture279910002NasdaqUnited States3845GeorgiaPublicBZET2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research640147005London AIMUnited Kingdom2836ForeignPublicVAL0.823000.600000.823000.53700Deal InformationTF Mergers & AcquisitionsBELGIUM - Biofield Corp (BC) of the US was granted an option to to raise its stake to ##% from ##%, by acquiring a ##% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnostic products, a unit of ValiRx PLC. Concurrently, BC agreed to acquire a ##% stake in VS.12/17/2008 2:20:08 PM09059191952J09059191939WBiofield CorpValiBIO SABiofield CorpValiRx PLChttp://www.alacrastore.com/storecontent/Thomson_M%26A/Biofield_Corp_intends_to_acquire_a_minority_stake_in_ValiBIO_SA_from_ValiRx_PLC-2035627040sdc/20356270402035627040Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqMeasuring, Medical, Photo Equipment; ClocksUnited StatesElectromedical and electrotherapeutic apparatus3845GAGeorgiaPublicBZET3845:Electromedical and electrotherapeutic apparatus3845:Electromedical and electrotherapeutic apparatusMeasuring, Medical, Photo Equipment; ClocksBelgiumLaboratory apparatus and furniture3821FFForeignSubsidiary279910002Mnfr breast cancer detect sysBiotechnology companyUnspecifiedStock1058011001Dec 17 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000Biofield Corp, based inAlpharetta, Georgia,manufactures and developsnon-invasive, portable,cost-effective technology fordetection of breast cancercalled Biofield BreastProliferation Detection System(BDS). The company wasestablished in 1992.Biofield Corp, based in Alpharetta, Georgia, manufacturesand develops non-invasive, portable, cost-effectivetechnology for detection of breast cancer called BiofieldBreast Proliferation Detection System (BDS). The company wasestablished in 1992.Biofield Corp, based in Alpharetta, Georgia, manufactures and develops non-invasive, portable, cost-effective technology for detection of breast cancer called Biofield Breast Proliferation Detection System (BDS). The company was established in 1992.1.000002.000003.000004.000005.000006.000007.000008.00000ValiBIO SA, based inGosselies, BElgium,manufactures cancer diagnosticproducts in 3 main areas:Nucleosomics, Hypergenomicsand HPV diagnostic tests. Thecompany was established inJuly 2007.ValiBIO SA, based in Gosselies, BElgium, manufactures cancerdiagnostic products in 3 main areas: Nucleosomics,Hypergenomics and HPV diagnostic tests. The company wasestablished in July 2007.ValiBIO SA, based in Gosselies, BElgium, manufactures cancer diagnostic products in 3 main areas: Nucleosomics, Hypergenomics and HPV diagnostic tests. The company was established in July 2007.0.000000.000000.000000.00000Y15 Dec 08Mon, 15 Dec 2008 00:00:00 ESTDate Announced: 12/15/2008Date Effective:Acq. Part. Int.Friendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.0000010.0000015.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.00000BELGIUM - Biofield Corp (BC)of the US was granted anoption to to raise its staketo 25% from 10%, by acquiringa 15% stake in ValiBIO SA(VS), a Gosselies-basedmanufacturer of cancerdiagnostic products, a unit ofValiRx PLC. Concurrently, BCagreed to acquire a 10% stakein VS.BELGIUM - Biofield Corp (BC) of the US was granted an option to to raise its stake to 25% from 10%, by acquiring a 15% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnostic products, a unit of ValiRx PLC. Concurrently, BC agreed to acquire a 10% stake in VS.BELGIUM - Biofield Corp (BC) of the US was granted an option to to raise its stake to 25%from 10%, by acquiring a 15% stake in ValiBIO SA (VS), a Gosselies-based manufacturer ofcancer diagnostic products, a unit of ValiRx PLC. Concurrently, BC agreed to acquire a 10%stake in VS.BELGIUM - Biofield Corp (BC) of the US was granted an option to to raise its stake to 25% from 10%, by acquiring a 15% stake in ValiBIO SA (VS), a Gosselies-based manufacturer of cancer diagnosticproducts, a unit of ValiRx PLC. Concurrently, BC agreed to acquire a 10% stake in VS.BELGIUM - Biofield Corp (BC) of the US was granted an option to to raise its stake to 25% from 10%, by acquiring a 15% stake in ValiBIOSA (VS), a Gosselies-based manufacturer of cancer diagnostic products, a unit of ValiRx PLC. Concurrently, BC agreed to acquire a 10%stake in VS.Intended0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Intended-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000003821:Laboratory apparatus and furniture279910002NasdaqUnited States3845GeorgiaPublicBZET2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research640147005London AIMUnited Kingdom2836ForeignPublicVAL0.000000.000000.000000.00000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/hmsc/3868-pdfhmsc/3868-pdfnormHemscott Company Fact Sheets provide business details, share data, valuation metrics, key statistics and dates, progress reports, major shareholders, directors, regulatory news, as well as five-year price charts, trading records and forecasts. 3868ValiRx PLCValiRx PLC9/17/2008 7:12:00 PM3868-pdfVAL188624.00ValiRx PLC: Company Facts Reportfacts3868-pdfCompany Profiles & FinancialsHemscott Company Reportshttp://www.alacrastore.com/storecontent/hmsc/3868-xlshmsc/3868-xlsnorm3868ValiRx PLCValiRx PLC9/17/2008 7:12:00 PMVAL188539.00ValiRx PLC: Company Insight Reportinsight3868-xlsCompany Profiles & FinancialsHemscott Company Reports